Challenging the current norm: Does health related quality of life data from reference populations accurately reflect baseline values in breast cancer patients? An observational cohort study comparing EORTC QLQ-C30 scores between the general Swedish population and baseline scores in breast cancer patients

被引:0
|
作者
Sjokvist, O. [1 ,2 ,3 ]
Hakansson, S. [1 ]
Pantiora, E. [1 ,2 ]
Karakatsanis, A. [1 ,2 ]
机构
[1] Uppsala Univ, Dept Surg Sci, S-75185 Uppsala, Sweden
[2] Uppsala Univ Hosp, Dept Breast Surg, Uppsala, Sweden
[3] Uppsala Univ Hosp, Dept Plast & Maxillofacial Surg, Uppsala, Sweden
来源
EJSO | 2021年 / 47卷 / 12期
关键词
Patient reported outcome measures; EORTC QLQ-C30; Quality of life; Breast cancer; RESPONSE SHIFT; QUESTIONNAIRE; SURVIVORS; IMPACT; PREDICTORS; GUIDELINES; THERAPY; WOMEN; CARE; AGE;
D O I
10.1016/j.ejso.2021.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Increased overall survival in breast cancer patients has led to a growing recognition of long-term effects of cancer treatment of patients' quality of life. Health related quality of life (HRQoL) data, as measured by patient reported outcome measures (PROMs), is increasingly incorporated into clinical practice and research. A commonly used method current available to interpret HRQoL PROMs data is by comparison to reference values, often obtained from sampling of the general population. The aim of this study was to assess whether HRQoL reference values derived from the general population are an accurate representation of the baseline values of an outpatient breast clinic population. Methods: A prospective observational cohort study was conducted by obtaining EORTC QLQ-C30 values for all patients offered an appointment in the outpatient breast clinic. These results were then compared to published baseline values in the general Swedish population, matched by gender and age. Results: 568 questionnaires were returned with a response rate of 81,1 %. The outpatient breast clinic cohort reported a higher grade of symptoms, lower function and lower quality of life compared to the equivalent reference population. Conclusion: This study challenges the assumption that the reference values accurately reflect those of the study population which clinicians and researchers need to account for in study design and clinical practice. (C) 2021 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:2971 / 2977
页数:7
相关论文
共 22 条
  • [1] ESTABLISHING BASELINE QUALITY OF LIFE REFERENCE DATA FOR THE EORTC QLQ-C30 IN LOCALLY ADVANCED BREAST CANCER PATIENTS
    Coens, Corneel
    Therasse, Patrick
    Efficace, Fabio
    Bottomley, Andrew
    QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 1998 - 1998
  • [2] The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values
    Mercieca-Bebber, Rebecca
    Costa, Daniel S. J.
    Norman, Richard
    Janda, Monika
    Smith, David P.
    Grimison, Peter
    Gamper, Eva-Marie
    King, Madeleine T.
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (11) : 499 - 506
  • [3] Data of real-world reference scores for EORTC QLQ-C30 and QLQ-BR23 at baseline in women with early breast cancer and other breast diseases
    Gebert, Pimrapat
    Dordevic, Adam David
    Roehle, Robert
    Hage, Anna Maria
    Karsten, Maria Margarete
    DATA IN BRIEF, 2022, 43
  • [4] Relationships among health-related quality of life indicators in cancer patients: A pooled study of baseline EORTC QLQ-C30 data from 6,739 patients
    Martinelli, F.
    Quinten, C.
    Coens, C.
    Flechtner, H.
    Gotay, C.
    Mendoza, T.
    Osoba, D.
    Reeve, B.
    Wang, X.
    Bottomley, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values
    Amin, Suvina
    Joo, Seongjung
    Nolte, Sandra
    Yoo, Hyun Kyoo
    Patel, Nikunj
    Byrnes, Hilary F.
    Costa-Cabral, Sara
    Johnson, Colin D.
    BMC CANCER, 2022, 22 (01)
  • [6] Determining the minimal clinically important difference for health related quality of life scores from the EORTC QLQ-C30 in lung cancer patients: an analysis of pooled data
    Maringwa, J.
    Coens, C.
    Quinten, C.
    Martinelli, F.
    Gotay, C.
    King, M.
    Osaba, D.
    Ringash, J.
    Bottomley, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 244 - 244
  • [7] Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values
    Suvina Amin
    Seongjung Joo
    Sandra Nolte
    Hyun Kyoo Yoo
    Nikunj Patel
    Hilary F. Byrnes
    Sara Costa-Cabral
    Colin D. Johnson
    BMC Cancer, 22
  • [8] MINIMALLY IMPORTANT DIFFERENCES FOR INTERPRETING EORTC QLQ-C30 SCORES IN MELANOMA, BREAST CANCER AND HEAD AND NECK CANCER PATIENTS ON BEHALF OF THE EORTC BREAST, HEAD AND NECK, MELANOMA AND QUALITY OF LIFE GROUPS
    Musoro, Z. J.
    Coens, C.
    Fiteni, F.
    Pogoda, K.
    Cardoso, F.
    Tribius, S.
    Singer, S.
    Oosting, S.
    Russell, N.
    Simon, C.
    Jean-Pascal, M.
    Gregoire, V
    Velikova, G.
    King, M. T.
    Gronvold, M.
    Cocks, K.
    Sprangers, M.
    Eggermont, A.
    Brandberg, Y.
    Bottomley, A.
    VALUE IN HEALTH, 2018, 21 : S78 - S78
  • [9] Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients
    Kontodimopoulos, N.
    Ntinoulis, K.
    Niakas, D.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (03) : 354 - 361
  • [10] Health-related quality of life indicators and overall quality of life: Results from a cluster analysis on baseline EORTC QLQ-C30 data from 6,739 cancer patients
    Coens, C.
    Martinelli, F.
    Quinten, C.
    Cleeland, C. S.
    Greimel, E.
    King, M.
    Ringash, J.
    Schmucker-Von Koch, J.
    Shi, Q.
    Bottomley, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)